Cargando…

Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance

Detalles Bibliográficos
Autor principal: Nishimura, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835558/
https://www.ncbi.nlm.nih.gov/pubmed/29396298
http://dx.doi.org/10.1016/j.ebiom.2018.01.019
_version_ 1783303840782614528
author Nishimura, Yukio
author_facet Nishimura, Yukio
author_sort Nishimura, Yukio
collection PubMed
description
format Online
Article
Text
id pubmed-5835558
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58355582018-03-06 Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance Nishimura, Yukio EBioMedicine Commentary Elsevier 2018-02-02 /pmc/articles/PMC5835558/ /pubmed/29396298 http://dx.doi.org/10.1016/j.ebiom.2018.01.019 Text en © 2018 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Nishimura, Yukio
Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
title Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
title_full Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
title_fullStr Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
title_full_unstemmed Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
title_short Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
title_sort losmapimod: a novel clinical drug to overcome gefitinib-resistance
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835558/
https://www.ncbi.nlm.nih.gov/pubmed/29396298
http://dx.doi.org/10.1016/j.ebiom.2018.01.019
work_keys_str_mv AT nishimurayukio losmapimodanovelclinicaldrugtoovercomegefitinibresistance